Forward Pharma A/S Operating Income

As of the most recent data (December 2021), FWP shows a operating income of $0. That compares with $1.2B in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FWP's operating income is now $0 (was $1.2B) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Forward Pharma A/S is outperforming or lagging.

Tracking FWP's operating income over time shows whether Forward Pharma A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $1.2B in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Forward Pharma A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $0) with ownership activity and broader fundamentals.

Forward Pharma A/S's operating income is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.